Video

A fib ablation in HFrEF patients gains momentum


 

EXPERT ANALYSIS FROM HEART RHYTHM 2018


The “signal” of benefit from AF ablation in heart failure patients in CABANA “replicates what was seen in CASTLE-AF. The results are highly consistent and very important regarding how to treat patients with AF and heart failure,” said Jeremy N. Ruskin, MD, professor of medicine at Harvard Medical School and director of the cardiac arrhythmia service at Massachusetts General Hospital, both in Boston. “The data strongly suggest that catheter ablation is helpful for restoring and preserving [heart] muscle function,” Dr. Ruskin said in a video interview. He noted that AF occurs in at least about a quarter of heart failure patients.

Other cardiologists at the meeting noted that, on the basis of the CASTLE-AF results alone, they have already become more aggressive about treating AF with ablation in patients with heart failure in routine practice.

Dr. Andrea M. Russo, professor and director of the electrophysiology and arrhythmia service at Cooper University Health Care in Camden, N.J. Mitchel L. Zoler/MDedge News

Dr. Andrea M. Russo

“The CASTLE-AF data confirmed that I can improve heart failure outcomes in patients with AF. You might think that the heart failure patients are too sick, but ablation is the appropriate treatment; you make their heart failure better,” said Andrea M. Russo, MD, professor and director of the electrophysiology and arrhythmia service at Cooper University Health Care in Camden, N.J.

“It adds to the armamentarium for treatment of patients with heart failure,” said Johannes Brachmann, MD, professor and chief of cardiology at the Coburg (Germany) Clinic and a senior coinvestigator for CASTLE-AF.

Dr. Johannes Brachmann, professor and chief of cardiology at the Coburg (Germany) Clinic Mitchel L. Zoler/MDedge News

Dr. Johannes Brachmann


Pages

Recommended Reading

Transcatheter valves underperform for native aortic regurgitation
MDedge Cardiology
Smoking increases heart failure risk in blacks
MDedge Cardiology
MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Cardiology
Is medical aid in dying suicide?
MDedge Cardiology
Lower glucose target linked to improved mortality in critically ill
MDedge Cardiology
Implanted pulse generator ups exercise tolerance in HF
MDedge Cardiology
CABANA: AF ablation ties drug management, with an asterisk for crossovers
MDedge Cardiology
Babies exposed to SSRIs in utero have decreased LV size
MDedge Cardiology
FDA approval expected for CCM in heart failure patients
MDedge Cardiology
FDA recalls HeartMate 3 LV assist device
MDedge Cardiology